Effectiveness of Erythropoietin in Hypertensive Hemodialysis Patients

Effectiveness of Erythropoietin in Hypertensive Hemodialysis Patients

Chronic renal failure (CRF) is one the most prevalent health problems among the elderly. On the fifth stage of CRF, the patient becomes eligible to hemodialysis. CRF-induced anemia is commonly treated with Erythropoietin (Epo). Information regarding the effectiveness of Epo in hypertensive hemodi...

Full description

Bibliographic Details
Main Authors:	Susannia Ibrahim, Ajeng Diantini, Budhi Prihartanto, Rudi Supriyadi
Format:	Article
Language:	English
Published:	Universitas Padjadjaran 2017-08-01
Series:	Pharmacology and Clinical Pharmacy Research

Similar Items

Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
by: Anak Agung Ngurah Putra Riana Prasetya, et al.
Published: (2021-01-01)

Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)

Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients
by: Amir-Hooshang Mohammadpour, et al.
Published: (2014-01-01)

Obesity may be erythropoietin dose-saving in hemodialysis patients
by: Ghada M. El-Kannishy, et al.
Published: (2018-06-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-06-01)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
by: Tomoaki Takata, et al.
Published: (2021-04-01)

Blood leptin levels and erythropoietin requirement in Iranian hemodialysis patients
by: Rahimi A, et al.
Published: (2008-12-01)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
by: Do Hyoung Kim, et al.
Published: (2021-12-01)

Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
by: T. Bulduk, et al.
Published: (2020-10-01)

Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
by: Bashaer M Muhammad-Baqir, et al.
Published: (2023-01-01)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
by: Yifan Zhu, et al.
Published: (2022-07-01)

Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality
by: Marisa Roldão, et al.
Published: (2022-03-01)

Effect of thyroid function status in hemodialysis patients on erythropoietin resistance and interdialytic weight gain
by: Fatemah Saleh Bin Saleh, et al.
Published: (2018-01-01)

Effects of L-Carnitine Added to Erythropoietin in Anemic Chronic Renal Failure Patients on Hemodialysis.
by: N Taheri, et al.
Published: (2006-10-01)

Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients
by: Li Cui, et al.
Published: (2024-12-01)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
by: Maryam Rahbar, et al.
Published: (2017-01-01)

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
by: Kristina Petrulienė, et al.
Published: (2017-01-01)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
by: Zorica M. Dimitrijevic, Tatjana P. Cvetkovic, Vidojko M. Djordjevic, Dusica D. Pavlovic, Nikola Z. Stefanovic, Ivana R. Stojanovic, Goran J. Paunovic, Radmila M. Velickovic-Radovanovic
Published: (2012-01-01)

Interleukin-6 gene polymorphisms and serum erythropoietin and hemoglobin in hemodialysis Iraqi patients
by: Mohanad Yasir Al-Radeef, et al.
Published: (2018-01-01)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.
by: Myoung Nam Bae, et al.
Published: (2015-01-01)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
by: Stephanie Munie, et al.
Published: (2021-07-01)

The Effect of Vitamin D Supplementation on Erythropoietin Utilization in Hemodialysis Patients: A Semi-experimental Study
by: Ameneh Najjar Firozjaei, et al.
Published: (2022-04-01)

Impact of hepcidin, interleukin 6, and other inflammatory markers with respect to erythropoietin on anemia in chronic hemodialysis patients
by: Ihab A. Ibrahim, et al.
Published: (2014-01-01)

The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients
by: N. Stepanova, et al.
Published: (2018-09-01)

Association of Erythropoietin, Adiponectin and Leptin levels with Anemia in uremic diabetic patients (Under hemodialysis):
by: Salim M. Al-Rubaâe, et al.
Published: (2011-01-01)

Living on High Altitudes Associated with Reduced Requirements of Exogenous Erythropoietin in Patients on Chronic Hemodialysis
by: André Benítez, et al.
Published: (2024-02-01)

ORIGINAL PAPER<br> Erythropoietin therapy in chronic renal failure patients prior to hemodialysis
by: Jacek Rysz, et al.
Published: (2005-04-01)

Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
by: Yosuke Aoki, et al.
Published: (2017-01-01)

Influence of Erythropoietin Dose and Albumin Level on the Plasma Brain Natriuretic Peptide in Hemodialysis Patients
by: Alsuwaida Abdulkareem
Published: (2006-01-01)

Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study
by: Muhammad Nadeem Ahsan, et al.
Published: (2021-11-01)

Effect of short-term erythropoietin therapy on insulin resistance and serum levels of leptin and neuropeptide Y in hemodialysis patients
by: Hamed M Osman, et al.
Published: (2017-01-01)

The Frequency of Resistance to Synthetic Erythropoietin and Its Risk Factors among Chronic Hemodialysis Patients in Kerman
by: Abbas Etminan, et al.
Published: (2018-01-01)

POS-610 PREDICTORS OF ERYTHROPOIETIN HIPORESPONSIVENESS IN PREVALENT PATIENTS ON HEMODIALYSIS: A CROSS-SECTIONAL STUDY
by: M. ROLDÃO, et al.
Published: (2021-04-01)

ACE gene polymorphism and its association with serum erythropoietin and hemoglobin &lrm;in Iraqi hemodialysis patients
by: Al-Radeef ‎MY, et al.
Published: (2019-07-01)

Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients
by: Knežević Violeta, et al.
Published: (2011-01-01)

The efficacy of darbepoetin alpha in hemodialysis patients resistant to human recombinant erythropoietin (rHuEpo)
by: Hejaili Fayez
Published: (2009-01-01)

PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
by: V. Novakivskyy
Published: (2017-03-01)

Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective study
by: Amal T. Khafagi, et al.
Published: (2022-05-01)

Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
by: Paweena Susantitaphong, et al.
Published: (2020-06-01)